VEGFA and cancer: As the VEGF signaling pathway was enriched in the ZNF385A- and ZNF346-high groups, we predicted the chemotherapeutic response of sorafenib for each sample, based on the Genomics of Drug Sensitivity in the Cancer (GDSC) database.